119 related articles for article (PubMed ID: 14633716)
1. Free and N-(2-hydroxypropyl)methacrylamide copolymer-bound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells.
Nishiyama N; Nori A; Malugin A; Kasuya Y; Kopecková P; Kopecek J
Cancer Res; 2003 Nov; 63(22):7876-82. PubMed ID: 14633716
[TBL] [Abstract][Full Text] [Related]
2. Geldanamycin induces heat shock protein expression through activation of HSF1 in K562 erythroleukemic cells.
Kim HR; Kang HS; Kim HD
IUBMB Life; 1999 Oct; 48(4):429-33. PubMed ID: 10632574
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models.
Banerji U; Walton M; Raynaud F; Grimshaw R; Kelland L; Valenti M; Judson I; Workman P
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7023-32. PubMed ID: 16203796
[TBL] [Abstract][Full Text] [Related]
4. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
McLean PJ; Klucken J; Shin Y; Hyman BT
Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone.
Clarke PA; Hostein I; Banerji U; Stefano FD; Maloney A; Walton M; Judson I; Workman P
Oncogene; 2000 Aug; 19(36):4125-33. PubMed ID: 10962573
[TBL] [Abstract][Full Text] [Related]
6. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
Bisht KS; Bradbury CM; Mattson D; Kaushal A; Sowers A; Markovina S; Ortiz KL; Sieck LK; Isaacs JS; Brechbiel MW; Mitchell JB; Neckers LM; Gius D
Cancer Res; 2003 Dec; 63(24):8984-95. PubMed ID: 14695217
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.
Demidenko ZN; Vivo C; Halicka HD; Li CJ; Bhalla K; Broude EV; Blagosklonny MV
Cell Death Differ; 2006 Sep; 13(9):1434-41. PubMed ID: 16311509
[TBL] [Abstract][Full Text] [Related]
9. The Ah receptor is a sensitive target of geldanamycin-induced protein turnover.
Chen HS; Singh SS; Perdew GH
Arch Biochem Biophys; 1997 Dec; 348(1):190-8. PubMed ID: 9390191
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates.
Kasuya Y; Lu ZR; Kopecková P; Minko T; Tabibi SE; Kopecek J
J Control Release; 2001 Jul; 74(1-3):203-11. PubMed ID: 11489496
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of hsp70-1/2 in geldanamycin-treated human non-small cell lung cancer H460 cells: involvement of intracellular calcium and protein kinase C.
Shu CW; Cheng NL; Chang WM; Tseng TL; Lai YK
J Cell Biochem; 2005 Apr; 94(6):1199-209. PubMed ID: 15696546
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
Schwock J; Geddie WR; Hedley DW
Cytometry A; 2005 Dec; 68(2):59-70. PubMed ID: 16228978
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts.
Eiseman JL; Lan J; Lagattuta TF; Hamburger DR; Joseph E; Covey JM; Egorin MJ
Cancer Chemother Pharmacol; 2005 Jan; 55(1):21-32. PubMed ID: 15338192
[TBL] [Abstract][Full Text] [Related]
15. Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro.
Wu WC; Kao YH; Hu PS; Chen JH
Exp Eye Res; 2007 Nov; 85(5):721-31. PubMed ID: 17870069
[TBL] [Abstract][Full Text] [Related]
16. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
[TBL] [Abstract][Full Text] [Related]
17. Geldanamycin activates Hsp70 response and attenuates okadaic acid-induced cytotoxicity in human retinal pigment epithelial cells.
Kaarniranta K; Ryhänen T; Sironen RK; Suuronen T; Elo MA; Karjalainen HM; Lammi MJ; Teräsvirta M; Uusitalo H; Salminen A
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):126-31. PubMed ID: 15950770
[TBL] [Abstract][Full Text] [Related]
18. [In vitro study of expression and effects of HSP70/HSP90 in nasopharyngeal carcinoma cells after thermotherapy].
Cui XB; Liu W; Li LX; Wang W; Zheng YQ; Guo LL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):628-31. PubMed ID: 19764559
[TBL] [Abstract][Full Text] [Related]
19. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.
Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J
Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism.
McCollum AK; Teneyck CJ; Sauer BM; Toft DO; Erlichman C
Cancer Res; 2006 Nov; 66(22):10967-75. PubMed ID: 17108135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
